18.1(top 1%)
Impact Factor
19.5(top 1%)
extended IF
145(top 2%)
H-Index
1.9K
authors
1.7K
papers
74.3K
citations
5.1K
citing journals
51.6K
citing authors

Most Cited Articles of Lancet Diabetes and Endocrinology,the

TitleYearCitations
Novel subgroups of adult-onset diabetes and their association with outcomes: a data-driven cluster analysis of six variables2018810
Vitamin D status and ill health: a systematic review2014732
Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome2014634
Type 2 diabetes and incidence of cardiovascular diseases: a cohort study in 1·9 million people2015585
Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials2019522
Long-term effects of lifestyle intervention or metformin on diabetes development and microvascular complications over 15-year follow-up: the Diabetes Prevention Program Outcomes Study2015501
Age-related and disease-related muscle loss: the effect of diabetes, obesity, and other diseases2014486
Diabetes: a 21st century challenge2014472
Practical recommendations for the management of diabetes in patients with COVID-192020463
Cardiovascular disease, chronic kidney disease, and diabetes mortality burden of cardiometabolic risk factors from 1980 to 2010: a comparative risk assessment2014446
Preconceptional and maternal obesity: epidemiology and health consequences2016429
Effect of a behavioural intervention in obese pregnant women (the UPBEAT study): a multicentre, randomised controlled trial2015424
Influence of maternal obesity on the long-term health of offspring2017421
10 years of denosumab treatment in postmenopausal women with osteoporosis: results from the phase 3 randomised FREEDOM trial and open-label extension2017419
Cardiovascular mortality, all-cause mortality, and diabetes incidence after lifestyle intervention for people with impaired glucose tolerance in the Da Qing Diabetes Prevention Study: a 23-year follow-up study2014410
Metabolically healthy obesity: epidemiology, mechanisms, and clinical implications2013409
Associations of type 1 and type 2 diabetes with COVID-19-related mortality in England: a whole-population study2020407
COVID-19 in people with diabetes: understanding the reasons for worse outcomes2020406
Obesity, inflammation, and the gut microbiota2015405
Sweetening of the global diet, particularly beverages: patterns, trends, and policy responses2016392
Exercise management in type 1 diabetes: a consensus statement2017391
Efficacy and safety of empagliflozin added to existing antidiabetes treatment in patients with type 2 diabetes and chronic kidney disease: a randomised, double-blind, placebo-controlled trial2014385
Estimated glomerular filtration rate and albuminuria for prediction of cardiovascular outcomes: a collaborative meta-analysis of individual participant data2015381
Risk factors for COVID-19-related mortality in people with type 1 and type 2 diabetes in England: a population-based cohort study2020375
Prevalence of diabetes and prediabetes in 15 states of India: results from the ICMR-INDIAB population-based cross-sectional study2017372